Clinical Trials Logo

Laryngospasm clinical trials

View clinical trials related to Laryngospasm.

Filter by:
  • None
  • Page 1

NCT ID: NCT04159116 Completed - Hypoxemia Clinical Trials

Prevention and Treatment of Laryngospasm and Hypoxemia Based on Risk Factors in Adult Outpatients Undergoing EGD

Start date: November 4, 2019
Phase: N/A
Study type: Interventional

The purpose of this study is to identify patient and provider-chosen factors that put patients at risk for the development of hypoxemia (oxygen saturation < 90% for 5 seconds) during endoscopy and to use this knowledge to develop a treatment protocol for specific causes of hypoxemia in adult esophagogastroduodenoscopy outpatients.

NCT ID: NCT01445847 Terminated - Laryngospasm Clinical Trials

The Effect of Intravenous Lidocaine on Post-extubation Laryngospasm

Start date: January 2012
Phase: N/A
Study type: Interventional

In the literature, we found no randomized clinical trials addressing the using of IV lidocaine as prophylaxis for postoperative laryngospasm among adults. The aim of this study was to assess the effects of IV lidocaine on the incidence of postoperative laryngospasm of adults patients.

NCT ID: NCT01288248 Active, not recruiting - Bradycardia Clinical Trials

Noninferiority Clinical Trial With Laryngeal Mask and Endotracheal Tube

Start date: January 2012
Phase: Phase 3
Study type: Interventional

The purpose of this study is to determine whether the use of laryngeal mask classic as method for securing the airway in the population of 2 years to 14 years is associated with risk of laryngospasm as compared with the use of endotracheal tube.

NCT ID: NCT01222169 Completed - Laryngospasm Clinical Trials

Laryngeal Reflex Study Under Propofol Anesthesia: Effect of Intravenous Lidocaine

LR6
Start date: September 2010
Phase: Phase 3
Study type: Interventional

To describe respiratory and laryngeal responses to laryngeal stimulation during propofol anesthesia in children. To determine whether the co-administration of lidocaine blunts these reflex responses. The outcome of primary interest is the reflex laryngospasm. Hypotheses: I: The severity of laryngospasm evoked by laryngeal stimulation is reduced 2 min. after iv. administration on 2mg/kg lidocaine in pediatric patients anesthetized with propofol (3mcg/ml). II:The incidence of laryngospasm elicited by controlled stimulation 10min. after iv. administration of lidocaine is equivalent to the response before the administration of lidocaine.

NCT ID: NCT00925613 Completed - Cough Clinical Trials

Benefits of Exchanging a Double Lumen Tube to a Proseal Laryngeal Mask or a Single Lumen Tube After a Thoracic Surgery

Start date: April 2009
Phase: Phase 3
Study type: Interventional

The purpose of this study is to determine whether exchange of the double lumen tube before emergence with a laryngeal mask airway (Proseal) or a tracheal tube will reduce cough at emergence.

NCT ID: NCT00665418 Terminated - Laryngospasm Clinical Trials

Sevoflurane and Laryngeal Reflex Responses in Pediatric Patients

Start date: February 2008
Phase: Phase 4
Study type: Interventional

To describe laryngeal and respiratory reflex responses after controlled laryngeal stimulation in pediatric patients anesthetized with sevoflurane and to compare the evoked responses at two levels of anesthesia. To determine whether laryngeal and respiratory reflex responses after controlled laryngeal stimulation are completely suppressed in subjects when anesthetized with a MACEI95 (EI = endotracheal intubation) sevoflurane Hypothesis: The incidence of apnea with laryngospasm evoked by laryngeal stimulation will be reduced by 20% (from 25% to 5%) when the end-tidal concentration of sevoflurane is increased from 2.5% (MAC50) to 4.7% (MACEI95)